SCHEMBL4183367

SCHEMBL4183367

Cc1cccc(CCNc2nc(-c3ccc(F)c(F)c3)ncc2N(C=O)Cc2ccccn2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
RECQL P46063 1/20 0.37
METAP2 P50579 2/20 0.36
METAP1 P53582 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HIF1A Q16665 1/20 0.34
POLB P06746 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
GBA1 P04062 1/20 0.33
CTNNB1 P35222 2/20 0.33
TCF7L2 Q9NQB0 2/20 0.33
USP1 O94782 1/20 0.33
WDR48 Q8TAF3 1/20 0.33
PGK1 P00558 1/20 0.33
VNN1 O95497 1/20 0.33
JAK3 P52333 1/20 0.33
CYP1A2 P05177 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178985 0.89 GBA1 (0.39) KDM4EHIF1APOLBGRIN1GRIN2B
SCHEMBL4183377 0.89 POLB (0.35) CYP2C19CYP2D6METAP2METAP1KDM4E
SCHEMBL4183066 0.88 CYP3A4 (0.39) CYP2C19CYP2D6KDM4EHIF1APOLB
SCHEMBL4179058 0.87 GBA1 (0.40) METAP2METAP1HIF1AGRIN1GRIN2B
SCHEMBL4185956 0.84 POLB (0.35) CYP2C19CYP2D6CYP2C9KDM4EHIF1A
SCHEMBL4184002 0.84 GBA1 (0.43) CYP2D6HIF1AGRIN1GRIN2BGBA1
SCHEMBL4185582 0.84 GBA1 (0.39) HIF1AGRIN1GRIN2BGBA1PGK1
SCHEMBL4176452 0.80 PGK1 (0.42) KDM4EHIF1AGRIN1GRIN2BGBA1
SCHEMBL4179062 0.80 KDM4E (0.43) METAP2METAP1KDM4EGRIN1GRIN2B
SCHEMBL13743133 0.79 KDM4E (0.46) KDM4EVNN1F2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods CYTOKINETICS, INCORPORATED 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods MYLK, MYH2, MYH10 CYP2C19 2307/4885CYP2D6 2173/4885CYP2C9 3010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.